Pay in 4 interest-free payments of $5.45 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Putting the evidence side by side Here is the blunt comparison: AOD 9604: 2.6 kg weight loss in 12 weeks (best result), failed six clinical trials, development terminated Semaglutide: 15 to 17 percent body weight loss over 68 weeks, FDA approved, thousands of study participants, consistent results across multiple trials There is no way to frame this comparison that puts AOD 9604 on equal footing with semaglutide when it comes to clinical evidence
It could mean that your bodys reaction is due to some effects of tirzepatide but not the medication itself
PubMed Thats a 79% risk reduction
Weight loss medications significantly enhance the effectiveness of lifestyle changes, such as a balanced diet and increased physical activity, leading to improved outcomes
None of these molecules is universally "better": the answer depends strictly on the research axis and the scientific question posed
US$ 23.40
US$ 24.40
US$ 29.61
